Café

© 2026 Longbridge｜Terms of Service Privacy Policy

CURX

CURX

5.2702.55%( -0.138 )

LongbridgeAI

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News

StockTitan

May 13, 2026 at 11:55 PM

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News

Login to unlock120characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Curanex Pharmaceuticals

CURX.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--